RESUMEN
BACKGROUND: Epilepsy prevalence is over 20% for those with ID. It is difficult to diagnose and treat and more likely to be treatment resistant. The evidence informing prescribing is sparse, particularly for new drugs such as perampanel (PMP). AIMS OF THE STUDY: This study seeks to strengthen the research evidence regarding PMP for people with ID by pooling information from two isolated and separately conducted studies: the UK-based Epilepsy Database Register (Ep-ID) and the data from the Kempenhaeghe clinic in the Netherlands. METHODS: A single data set of comparable data was created and analysed under agreement and supervision of a UK statistician. RESULTS: Seizure reduction within twelve months was evident in 62% of Dutch and 47% of UK patients. Retention rates were higher for those in the UK (P = .01) and for patients with moderate to profound ID, whilst side effects were more prominent in the Dutch cohort. CONCLUSIONS: Comparable rates of seizure reduction are in line with estimates for non-ID patients, adding to the evidence suggesting that PMP has a similar impact on those with ID. Taking a European perspective and sharing data across centres can help strengthen the evidence for prescribing antiepileptic drugs in the ID population.
Asunto(s)
Anticonvulsivantes/uso terapéutico , Epilepsia/complicaciones , Epilepsia/tratamiento farmacológico , Discapacidad Intelectual/complicaciones , Piridonas/uso terapéutico , Adolescente , Adulto , Anticonvulsivantes/efectos adversos , Estudios de Cohortes , Bases de Datos Factuales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Países Bajos , Nitrilos , Piridonas/efectos adversos , Sistema de Registros , Convulsiones/tratamiento farmacológico , Convulsiones/epidemiología , Resultado del Tratamiento , Reino Unido , Adulto JovenRESUMEN
PURPOSE: The study aimed to describe the frequency and severity of self-injurious, stereotyped, and aggressive/destructive behavior in adults with both epilepsy and intellectual disability (ID) who reside at a tertiary epilepsy center and to investigate the associations between challenging behavior and epilepsy and ID characteristics. METHOD: The frequency and severity of self-injurious, (motoric) stereotyped, and aggressive/destructive behavior among 189 patients was assessed using the Behavior Problem Inventory. Comparisons were made with an adult reference population with ID, based on gender, to determine whether the behavior was clinically deviant. Epilepsy characteristics, including age at onset, epilepsy type, seizure types, seizure frequency, and use of antiepileptic drugs (AEDs), were retrieved from patient files. The level of ID was classified using the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5) and an ID domain discrepancy was allocated if there was a substantial difference between two domains of adaptive behavior within a subject. RESULTS: Self-injurious behavior was present in 35% of subjects, stereotyped behavior in 60%, and aggressive/destructive behavior in 63%. The behavior exceeded clinical norms in 7%, 18%, and 12%, respectively. Aggression was the behavior evaluated most often as being problematic, despite its reported frequency being the lowest. When adjusting for level of ID and use of psychotropic medication, logistic regression analyses showed that self-injurious behavior was significantly associated with a lower number of AEDs (odds ratio (OR)â¯=â¯0.4); that stereotyped behavior was significantly associated with a higher number of seizure types (ORâ¯=â¯1.4) and a lower number of AEDs (ORâ¯=â¯0.4); and that aggression was significantly associated with the presence of an ID domain discrepancy (ORâ¯=â¯3.1). CONCLUSION: Challenging behavior is a serious issue among adults with epilepsy and ID. Although some of the epilepsy and ID characteristics seemed to contribute independently to these types of challenging behavior, the effects of epilepsy-related characteristics are modest when compared with ID.
Asunto(s)
Epilepsia/psicología , Discapacidad Intelectual/psicología , Adolescente , Adulto , Edad de Inicio , Anciano , Agresión , Anticonvulsivantes/uso terapéutico , Estudios Transversales , Manual Diagnóstico y Estadístico de los Trastornos Mentales , Epilepsia/complicaciones , Femenino , Humanos , Discapacidad Intelectual/complicaciones , Masculino , Persona de Mediana Edad , Psicotrópicos/uso terapéutico , Convulsiones/fisiopatología , Convulsiones/psicología , Conducta Autodestructiva/complicaciones , Conducta Autodestructiva/tratamiento farmacológico , Conducta Autodestructiva/psicología , Conducta Estereotipada , Adulto JovenRESUMEN
OBJECTIVE: In a prospective study we tested whether muscle ultrasonography can differentiate between amyotrophic lateral sclerosis (ALS) and mimics. Furthermore, we assessed the ability of ultrasonography to identify subclinical lower motor neuron involvement. METHODS: In 59 patients, suspected for adult onset motor neuron disease, ultrasound scans were made of 12 different muscle groups. Echo intensity was determined and each muscle was screened for fasciculations. Ultrasonography was considered diagnostic for ALS when echo intensity was 1.5 SD above normal in at least two muscles and fasciculations were present in at least four muscles. RESULTS: Ultrasonography differentiated between ALS and mimics with 96% sensitivity and 84% specificity. In the 27 ALS patients, ultrasonography detected 15 regions with lower motor neuron involvement that were negative using either clinical examination or needle EMG. CONCLUSIONS: Muscle ultrasound can differentiate between amyotrophic lateral sclerosis and mimics with high sensitivity and specificity, and is a sensitive tool to screen for regional lower motor neuron involvement. SIGNIFICANCE: Muscle ultrasonography is a promising tool in the diagnostic work up of ALS.
Asunto(s)
Esclerosis Amiotrófica Lateral/diagnóstico , Músculo Esquelético/diagnóstico por imagen , Adulto , Anciano , Esclerosis Amiotrófica Lateral/diagnóstico por imagen , Diagnóstico Diferencial , Electromiografía , Fasciculación/diagnóstico , Fasciculación/diagnóstico por imagen , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedad de la Neurona Motora/diagnóstico , Enfermedad de la Neurona Motora/diagnóstico por imagen , Neuronas Motoras/fisiología , Examen Neurológico , Estudios Prospectivos , Sensibilidad y Especificidad , Método Simple Ciego , UltrasonografíaRESUMEN
OBJECTIVE: We performed a longitudinal study to assess structural muscle changes in amyotrophic lateral sclerosis (ALS) using ultrasonography. METHODS: During a follow-up of 6 months, ultrasonography parameters (muscle thickness, echo intensity and fasciculations) were obtained from 6 muscle groups in 31 ALS patients, together with strength and scores on the revised ALS functional rating scale (ALSFRS-r). RESULTS: At baseline, we found an increased echo intensity and decreased thickness, and these parameters correlated with lower strength. Moreover, ultrasound abnormalities were also detected in muscles with preserved strength. Longitudinal changes in echo intensity, muscle thickness and fasciculations showed large variations between patients. Rates of change in ultrasound parameters did not correlate with changes in ALSFRS-r or strength. CONCLUSION: In patients with ALS ultrasound abnormalities can be found in muscles with preserved strength. The pattern of ultrasonographic muscle changes in ALS is highly variable and shows no evident correlation with functional measures. SIGNIFICANCE: Ultrasonography is not suitable to monitor disease progression in ALS.